1-9 of 9
Elizabeth Brem
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Somatic mutations and clinical outcomes in primary central nervous system lymphoma among hispanic and non-hispanic patients: A study from the University of California hematologic malignancies consortium (UCHMC)

Free
Haifaa Abdulhaq, Omar Mahmood, nathan Futoran, Sani Bukari, Calvin Chen, Joseph Tuscano, Aaron Tsumura, Tamer Othman, Elizabeth Brem, Chenchen Niu, Benjamin Heyman, Michelle Don, Azra Borogovac, Matthew Wieduwilt, Maher Albitar
Journal: Blood
Blood (2025) 146 (Supplement 1): 1755.
https://doi.org/10.1182/blood-2025-1755
Published: 2025
Journal Articles

Multicenter real-world outcomes in limited stage (LS) diffuse large B-cell lymphoma (DLBCL) treated with abbreviated immunochemotherapy

Free
Hua-Jay Cherng, Drew Gerber, Chijioke Nze, Shahzeem Bhayani, David Russler-Germain, Ahmed Alnughmush, Paul Hampel, Kelsey Kille, Danielle Wallace, David Qualls, Reid Merryman, Jaden Brooks, Allison Bock, Juan Ramirez, Yumeng Zhang, Julio Chavez, Katelynn Granger, Katherine Antel, Cassandra Duarte, Ajay Major, Sirui Ma, Michael Spinner, Alyssa Mackay, Bei Hu, Manoj Rai, Stephen Spurgeon, Benjamin Lee, Jean Doh, Elizabeth Brem, Nicole Altomare, Reem Karmali, Robert Ryan, Yun Kyoung Tiger, Jordan Carter, Daniel Landsburg, Swetha Thiruvengadam, Alan Skarbnik, Yun Choi, David Bond, Ravand Samaeekia, Helen Ma, Seda Tolu, Jennifer Amengual, Alex Herrera, Barbara Pro
Journal: Blood
Blood (2025) 146 (Supplement 1): 471.
https://doi.org/10.1182/blood-2025-471
Published: 2025
Journal Articles

Efficacy and safety of loncastuximab tesirine and rituximab (Lonca-R) followed by dose-adjusted rituximab with etoposide, doxorubicin, cyclophosphamide, vincristine and prednisone (DA-R-EPOCH) in previously untreated high-risk diffuse large B-cell lymphoma (DLBCL): Preliminary results from a University of California Malignancy Consortium (UCHMC) Phase II trial, UCDCC#303.

Free
Jacqueline Hsieh-Wong, Naseem Esteghamat, Rasmus Hoeg, Mehrdad Abedi, Sheila Firoozan, Aaron Rosenberg, Ashley Trane, Aneeqa Zafar, Shuai Chen, Siyao Li, Matthew Wieduwilt, Lloyd Damon, Benjamin Heyman, Haifaa Abdulhaq, Elizabeth Brem, Deepa Jeyakumar, Gary Schiller, Joseph Tuscano
Journal: Blood
Blood (2025) 146 (Supplement 1): 1966.
https://doi.org/10.1182/blood-2025-1966
Published: 2025
Journal Articles

Odronextamab Monotherapy in Previously Untreated Patients with High-Risk Follicular Lymphoma (FL): Results of the Safety Lead-in of the Phase 3 Olympia-1 Study

Free
Elizabeth Brem, Wojciech Jurczak, David Belada, Jaime Perez de Oteyza, Aranzazu Alonso Alonso, Fevzi Altuntas, Michał Kwiatek, Joshua Brody, Ernesto Perez Persona, Mustafa Yenerel, Monica Tani, Jingxian Cai, Priya Deshpande, Saleem Shariff, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Ashish Risal, Ruemu Birhiray
Journal: Blood
Blood (2024) 144 (Supplement 1): 4411.
https://doi.org/10.1182/blood-2024-200080
Published: 2024
Journal Articles

Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study

Free
Pierluigi Porcu, MD, Brad M. Haverkos, MDMPH,MS, Onder Alpdogan, MD, Marcelo Capra, MD PhD, Tatyana A. Feldman, MD, Elizabeth Brem, MD, Anusha Vallurupalli, MD, Jonathan E. Brammer, MD, Ana Schriefer, Juliana Pereira, MD PhD, Anil Tulpule, MD, Stefan K. Barta, MD MRCP, MS, Locke J. Bryan, MD, Richard Trauger, Sebastian Obrzut, John Gutheil, MD, Afton Katkov, MSc, Robert McRae, Ivor Royston, MD, Douglas V. Faller, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 465.
https://doi.org/10.1182/blood-2019-132004
Published: 2019
Journal Articles

Statins Enhance the Efficacy of BH3 Mimetics in Multiple Myeloma

Free
Dennis Juarez, BS, David Alexander Fruman, PhD, Angela G. Fleischman, MD PhD, Elizabeth Brem, MD, Grace Diep, Undergraduate, Falisha Nguyen, Undergraduate
Journal: Blood
Blood (2018) 132 (Supplement 1): 1989.
https://doi.org/10.1182/blood-2018-99-120205
Published: 2018
Journal Articles

Potential Impact of Consolidation Radiation Therapy for Advanced Hodgkin Lymphoma: A Secondary Modeling of SWOG S0816 with Receiver Operating Characteristic Analysis

Free
Chul S. Ha, MD, Hongli Li, MS, Heiko Schoder, MD, Chelsea C Pinnix, MD, Elizabeth Brem, MD, Nancy L. Bartlett, MD, Andrew M. Evens, DO, MSc, Eric D. Hsi, MD, Lisa M. Rimsza, MD, John P. Leonard, MD, Brad S Kahl, MD, Michael L. Leblanc, PhD, Sonali M. Smith, MD, Louis S. Constine, MD, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2927.
https://doi.org/10.1182/blood-2018-99-113133
Published: 2018
Journal Articles

A Functional Characterization of BCL2-Family Members Identifies BH3 Mimetics As Potential Therapeutics in T-Cell Lymphomas

Free
Raphael Koch, MD, Elizabeth Brem, MD, Rachael Clark, MD PhD, Thomas S. Kupper, MD, Anthony Letai, MD PhD, David M. Weinstock, MD
Journal: Blood
Blood (2016) 128 (22): 292.
https://doi.org/10.1182/blood.V128.22.292.292
Published: 2016
Journal Articles

Alterations In Mitochondrial Priming May Be a Mechanism For Acquired Resistance To Therapy In Diffuse Large B-Cell Lymphoma

Free
Elizabeth Brem, MD, Francisco J. Hernandez-Ilizaliturri, MD, Myron S. Czuczman, MD, Scott Rodig, M.D., Ph.D., Anthony G. Letai, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1764.
https://doi.org/10.1182/blood.V122.21.1764.1764
Published: 2013